These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33838463)

  • 21. Prevalence of Hearing Loss Among a Representative Sample of Canadian Children and Adolescents, 3 to 19 Years of Age.
    Feder KP; Michaud D; McNamee J; Fitzpatrick E; Ramage-Morin P; Beauregard Y
    Ear Hear; 2017; 38(1):7-20. PubMed ID: 27556530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal study of pure-tone thresholds in older persons.
    Lee FS; Matthews LJ; Dubno JR; Mills JH
    Ear Hear; 2005 Feb; 26(1):1-11. PubMed ID: 15692300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equivalence and test-retest reproducibility of conventional and extended-high-frequency audiometric thresholds obtained using pure-tone and narrow-band-noise stimuli.
    John AB; Kreisman BM
    Int J Audiol; 2017 Sep; 56(9):635-642. PubMed ID: 28388868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audiometric profiles in children with speech sound disorder: Subclinical hearing loss as a potential factor.
    Nakeva von Mentzer C
    Clin Linguist Phon; 2021 Sep; 35(9):847-873. PubMed ID: 33225761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended high-frequency bone conduction audiometry Calibration of bone conductor transducers in the conventional and extended high-frequency range.
    Rhebergen KS
    Int J Audiol; 2023 Feb; 62(2):182-191. PubMed ID: 35195500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fixed-Level Frequency Threshold Testing for Ototoxicity Monitoring.
    Rieke CC; Clavier OH; Allen LV; Anderson AP; Brooks CA; Fellows AM; Brungart DS; Buckey JC
    Ear Hear; 2017; 38(6):e369-e375. PubMed ID: 28362673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pure-tone hearing thresholds of otologically healthy 14-year-old children.
    Rahko-Laitila P; Karma P; Laippala P; Salmelin R; Sipilä M; Manninen M; Rahko T
    Audiology; 2001; 40(4):171-7. PubMed ID: 11521708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suprathreshold auditory processes in listeners with normal audiograms but extended high-frequency hearing lossa).
    Mishra SK; Fu QJ; Galvin JJ; Galindo A
    J Acoust Soc Am; 2023 May; 153(5):2745. PubMed ID: 37133816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Audiological assessment of hearing-impaired children under age 3 and their later pure tone audiometry].
    Takahashi Y; Sawada A; Mori Y; Iwaki T; Kawashima T; Miyazaki Y; Sumi M; Mishiro Y; Kubo T
    Nihon Jibiinkoka Gakkai Kaiho; 2002 Sep; 105(9):920-4. PubMed ID: 12400168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Importance of Extended High Frequencies in Hearing Evaluation of Pediatric Patients with Type 1 Diabetes.
    Güven SG; Binay Ç
    J Clin Res Pediatr Endocrinol; 2023 May; 15(2):127-137. PubMed ID: 36416457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infant air and bone conduction tone burst auditory brain stem responses for classification of hearing loss and the relationship to behavioral thresholds.
    Vander Werff KR; Prieve BA; Georgantas LM
    Ear Hear; 2009 Jun; 30(3):350-68. PubMed ID: 19322084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient-evoked otoacoustic emissions in a group of professional singers who have normal pure-tone hearing thresholds.
    Hamdan AL; Abouchacra KS; Zeki Al Hazzouri AG; Zaytoun G
    Ear Hear; 2008 Jun; 29(3):360-77. PubMed ID: 18382377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
    Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended high-frequency audiometry in patients with acoustic trauma.
    Balatsouras DG; Homsioglou E; Danielidis V
    Clin Otolaryngol; 2005 Jun; 30(3):249-54. PubMed ID: 16111421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hearing and hearing loss in 5-year-old children. Pure-tone thresholds and the effect of acute otitis media.
    Karma P; Sipilä M; Rahko T
    Scand Audiol; 1989; 18(4):199-203. PubMed ID: 2609096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hearing loss in children with Fabry disease.
    Suntjens E; Dreschler WA; Hess-Erga J; Skrunes R; Wijburg FA; Linthorst GE; Tøndel C; Biegstraaten M
    J Inherit Metab Dis; 2017 Sep; 40(5):725-731. PubMed ID: 28567540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-frequency hearing loss and wideband middle ear impedance in children with otitis media histories.
    Margolis RH; Saly GL; Hunter LL
    Ear Hear; 2000 Jun; 21(3):206-11. PubMed ID: 10890728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.